Need Help?

MDS Sequencing Project_Cancer Cell

Myelodysplastic syndromes (MDS) are uncommon entities, heterogeneous clinically and cytogenetically. The aim of the present study is to determine genetic alteration in this subset of patients. Expected results: Identification of new aberrations and genetic markers in order to detect novel genes involved in MDS 5q-response to Lenalidomide's treatment.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001001058 Illumina HiSeq 2000 42
Publications Citations
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.
Cancer Cell 26: 2014 509-520
115